Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 3 | 6666 | 937 | 0.9500 | 0.8682 | 0.1406 | 0.1425 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 1 | 4894 | 612 | 0.7101 | 0.7398 | 0.1251 | 0.1305 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 2 | 5229 | 702 | 0.7507 | 0.7398 | 0.1343 | 0.1305 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 3 | 5271 | 697 | 0.7585 | 0.7398 | 0.1322 | 0.1305 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 3782 | 731 | 0.5059 | 0.4677 | 0.1933 | 0.1974 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 2 | 3291 | 651 | 0.4378 | 0.4677 | 0.1978 | 0.1974 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 3469 | 698 | 0.4595 | 0.4677 | 0.2012 | 0.1974 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 1 | 3373 | 297 | 0.5101 | 0.4962 | 0.0881 | 0.0847 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 2 | 3208 | 272 | 0.4869 | 0.4962 | 0.0848 | 0.0847 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 0.000 | uM | 72 | hr | 3 | 3226 | 262 | 0.4915 | 0.4962 | 0.0812 | 0.0847 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 1 | 2621 | 401 | 0.3681 | 0.3841 | 0.1530 | 0.1420 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 2 | 2639 | 411 | 0.3695 | 0.3841 | 0.1557 | 0.1420 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 0.316 | uM | 72 | hr | 3 | 2833 | 332 | 0.4147 | 0.3841 | 0.1172 | 0.1420 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 1 | 2325 | 439 | 0.3128 | 0.3086 | 0.1888 | 0.1792 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 2 | 2322 | 411 | 0.3169 | 0.3086 | 0.1770 | 0.1792 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 3 | 2155 | 370 | 0.2960 | 0.3086 | 0.1717 | 0.1792 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 1 | 1834 | 545 | 0.2138 | 0.2001 | 0.2972 | 0.2904 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 2 | 1699 | 514 | 0.1965 | 0.2001 | 0.3025 | 0.2904 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 3 | 1573 | 427 | 0.1900 | 0.2001 | 0.2715 | 0.2904 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 1 | 2155 | 340 | 0.3010 | 0.2995 | 0.1578 | 0.1548 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 2 | 2104 | 329 | 0.2943 | 0.2995 | 0.1564 | 0.1548 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 3 | 2151 | 323 | 0.3031 | 0.2995 | 0.1502 | 0.1548 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 1 | 1562 | 486 | 0.1784 | 0.1736 | 0.3111 | 0.3188 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 2 | 1562 | 528 | 0.1715 | 0.1736 | 0.3380 | 0.3188 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 3 | 1488 | 457 | 0.1710 | 0.1736 | 0.3071 | 0.3188 |